Pharmacodynamic Effects of Ranolazine Versus Amlodipine on Platelet Reactivity
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT01490255
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose diagnostic
- Phase
- Phase 4
- Enrolled
- 100 participants
- Registry
-
NCT01490255
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Italy
- Registry status
- Unknown status
Technical summary
Registry record NCT01490255. Randomized; single masking; primary purpose diagnostic. Start 2012-01 (registry gives no type); primary completion 2014-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Pharmacodynamic Effects of Ranolazine Versus Amlodipine on Platelet Reactivity
- Acronym
- ROMAN
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Ranolazine
- Intervention (Drug)
- Amlodipine
- Lead sponsor
- University of Roma La Sapienza
Record details
- Record id
cardio:ct-nct01490255- Content hash
26c5db1fb8b632ffb0cc4e70c9108024f0d8a183df20775971e73f5e3ecccd6a